Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 900 participants.
Also called NCT06911632
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 900 participants
- Sponsor
- Registry
-
NCT06911632
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06911632. Randomized; no masking; primary purpose diagnostic. Start 2025-07-23 (actual); primary completion 2028-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Acronym
- MOMENTOUS
- Condition
- Pulmonary Hypertension
- Condition
- Interstitial Lung Disease (ILD)
- Intervention (Device)
- ECG-based AI Device - Results Returned to Investigator
- Intervention (Procedure)
- Echocardiogram and Right Heart Catheterization
- Intervention (Device)
- ECG-based AI Device - Results Not Returned to Investigator
- Lead sponsor
- Tempus AI
- Collaborator
- United Therapeutics
Record details
- Record id
cardio:ct-nct06911632- Content hash
86757f876e2926ce6476a429ade216957c0f8489e48b82b681c6b2ddd2d25e1f